Discovering new treatments for human diseases is an enormously complicated challenge; Even after widespread research to develop a biological understanding of a disease, an actual therapeutic that can improve the eminence of life must still be found. This process often takes years of research, without the creation and testing of millions of drug-like compounds in an effort to find a just a few worthwhile drug treatment candidates. These high-throughput monitors are often automated in sophisticated laboratories and are expensive to perform.

Recently, deep learning with neural systems has been applied in virtual drug screening 1,2,3, which attempts to substitute or augment the high-throughput screening procedure with the use of computational methods in order to improve its speed and success rate 4. Conventionally, virtual drug screening has used only the experimental data from the specific disease being studied. However, as the volume of experimental drug screening data across many diseases carry on to grow, several research groups have demonstrated that data from multiple diseases can be leveraged with multitask neural networks to improve the virtual screening effectiveness.

Drug Discovery of Rare Diseases:

Rare disease research has reached a listing point, with the confluence of scientific and technologic developments that if appropriately connected, could lead to key innovations and treatments for this set of devastating conditions. Drug companies are developing their new research and development (R&D) approach. Rather than only pursue blockbuster therapeutics for heterogeneous, common diseases, drug companies have gradually begun to shift their focus to rare diseases.

• Hepatocyte-targeted RNAi Therapeutics
• Developing Therapeutics for Major Unmet Medical Needs
• Challenges of Rare Disease Drug Development
• Rare hematological malignancies

Many more Interesting Research Topics are discussed at our International Event on Drug Discovery Congress 2018 going to be held at Dubai, UAE on April 16-17, 2018

For more details Visit our website: https://drugchemistry.pharmaceuticalconferences.com/

Contact us:

Monty

Program manager

Drug Discovery Congress

Mail ID: drugdesign@pharmaceuticalconferences.org